Clinical Trial Update: Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating atorvastatin with alkali therapy in autosomal dominant polycystic kidney disease and chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease
• Chronic Kidney Disease

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Taipei Medical University Shuang Ho Hospital | Conditions: Autosomal Dominant Polycystic Kidney Disease, Chronic Kidney Diseases | Phase 2 | Status: ENROLLING_BY_INVITATION